IL1B and neoplasm: Although this study supported the hypothesis that anti-tumor immune response of the combination of anti-IL-1β antibody and anti-PD-1 antibody is context-dependent by showing the antitumor immune response is affected by the stromal heterogeneity in PDACs, it is limited by its hypothesis-generating nature in most parts of the study.